STAAR Surgical Company
STAA
$29.29
-$1.92-6.15%
NASDAQ
| 04/03/2026 | 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 70.41% | -298.10% | -542.54% | -673.47% | -564.64% |
| Total Depreciation and Amortization | 1.23% | 20.72% | 51.66% | 58.90% | 52.47% |
| Total Amortization of Deferred Charges | 867.92% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.78% | 44.31% | 58.20% | 30.31% | 59.72% |
| Change in Net Operating Assets | -3,585.14% | -94.20% | 147.83% | 213.09% | 126.07% |
| Cash from Operations | -329.39% | -317.68% | -163.07% | -176.55% | -128.26% |
| Capital Expenditure | 75.61% | 75.12% | 52.46% | 35.83% | 4.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 187.92% | 245.60% | 1,533.02% | -71.48% | -120.17% |
| Cash from Investing | 132.79% | 178.25% | 367.08% | -88.47% | -149.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 74.55% | 49.39% | 22.36% | -5.03% |
| Issuance of Common Stock | 33.48% | -53.10% | -56.27% | -84.39% | -83.09% |
| Repurchase of Common Stock | -449.39% | -430.30% | -467.36% | -293.90% | -5.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -836.11% | -179.58% | -174.42% | -134.06% | -94.39% |
| Foreign Exchange rate Adjustments | 887.50% | 229.34% | -71.47% | 277.92% | 115.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.97% | 123.13% | -66.77% | -126.15% | -137.98% |